Collagen Peptides for Skin: 2026 Market Surge Driven by 12.8% CAGR, Clinical Efficacy & Hydrolyzed vs. Marine Formulation Guide
Published: July 9, 2026 04:52
Author: Mei Ito
Abstract: The collagen peptides for skin market is projected to surge at a 12.8% CAGR through 2026, driven by clinical efficacy in dermal regeneration. Hydrolyzed (Type I/III) and marine (Type I) formulations dominate, with marine offering higher bioavailability but lower cost-efficiency. Key brands (Vital Proteins, Neocell) compete via GRAS/FDA certifications and third-party purity testing. Advantages include improved elasticity and hydration; limitations involve variable absorption rates. Selection criteria prioritize peptide chain length (<3kDa), solubility, and cold-chain logistics for liquid formats. Industry trends favor sustainable sourcing and multi-ingredient synergies, demanding rigorous factory GMP audits.